Expert.ai S.p.A. (EXAI)
| Market Cap | 143.89M |
| Revenue (ttm) | 30.62M |
| Net Income (ttm) | -10.42M |
| Shares Out | 97.34M |
| EPS (ttm) | n/a |
| PE Ratio | n/a |
| Forward PE | 65.00 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,454,597 |
| Open | 4.600 |
| Previous Close | 4.840 |
| Day's Range | 4.600 - 4.840 |
| 52-Week Range | 3.800 - 7.910 |
| Beta | 1.90 |
| Analysts | Hold |
| Price Target | n/a |
| Earnings Date | Sep 30, 2025 |
About EXAI
Expert.ai S.p.A., an artificial intelligence (AI) platform company, develops and sells cognitive computing software products based on AI algorithms to read and understand written language worldwide. The company offers expert.ai Platform that captures the strategic value of language data; expert.ai Answers, a customer support automation software that allows human like interaction between customers and internal staff, using the language of business and users; expert.ai Discover, a text analytics, and extraction and categorization software; expert... [Read more]
Financial Performance
In 2024, Exscientia's revenue was 29.58 million, a decrease of -18.58% compared to the previous year's 36.33 million. Losses were -10.06 million, 2.07% more than in 2023.
Financial numbers in EUR Financial StatementsNews
HAYA Therapeutics Appoints Former Exscientia Executive Dr. Richard Law as Chief Business Officer
LAUSANNE, Switzerland & SAN DIEGO--(BUSINESS WIRE)-- #Exscientia--HAYA Therapeutics appoints former Exscientia executive Dr. Richard Law as Chief Business Officer.
Exscientia Achieves Milestones for Two Programmes in Sanofi Collaboration
OXFORD, England--(BUSINESS WIRE)--Exscientia plc (Nasdaq: EXAI) today announced the advancement of two additional discovery programmes within its collaboration with Sanofi, with Exscientia receiving a...
Exscientia to Present New Preclinical Data for AI-designed LSD1 and MALT1 Inhibitors at ENA 2024
OXFORD, England--(BUSINESS WIRE)--Exscientia plc (Nasdaq: EXAI) today announced three abstracts to be presented at the 36th EORTC-NCI-AACR (ENA) Symposium 2024 from October 23-25, in Barcelona, Spain....
Brilliant NextGen Will Expand Solutions for Builders Through its Acquisition by Private Investors
SAN MATEO, Calif.--(BUSINESS WIRE)--Brilliant, the designer and manufacturer of innovative smart home controls and home automation systems shares its acquisition by Almeida Strategic Investments, led ...
BreachBits and SecurityStudio Collaborate to Enhance Virtual CISO Credentials and Automated Capabilities
ANNAPOLIS, Md.--(BUSINESS WIRE)--BreachBits is pleased to announce its collaboration with SecurityStudio for 2024. SecurityStudio is a cyber risk management platform that focuses on holistic informati...
AM Best Comments on Credit Ratings of American National Group's Members Following Announced Coinsurance Agreement With Reinsurance Group of America, Incorporated
OLDWICK, N.J.--(BUSINESS WIRE)-- #insurance--AM Best has commented that the Financial Strength Rating of A (Excellent) and the Long-Term Issuer Credit Ratings of “a+” (Excellent) of American National ...
Suffolk Texas Named Best Place to Work for Two Consecutive Years
DALLAS--(BUSINESS WIRE)--Suffolk, one of the largest and most innovative real estate and construction enterprises in the country, is proud to announce that the Dallas Business Journal has named its Da...
Exscientia to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference
OXFORD, England--(BUSINESS WIRE)--Exscientia plc (Nasdaq: EXAI) today announced that David Hallett, interim Chief Executive Officer and Chief Scientific Officer, will participate in a fireside chat at...
Exscientia Business Update for Second Quarter and First Half 2024
OXFORD, U.K.--(BUSINESS WIRE)--Exscientia plc (Nasdaq: EXAI): Recent advancements in the Company's pipeline, collaborations and operations, as well as financial results for the second quarter and firs...
Recursion CEO on $688M Exscientia acquisition: Hope to bring better medicines to patients sooner
Chris Gibson, Recursion co-founder and CEO, joins 'Squawk Box' to discuss the company's $688 million acquisition of Exscientia, the use of AI in drug discovery, and more.
AI-Powered Drug Discovery Firm Exscientia To Merge With Nvidia-Partner Recursion Pharmaceuticals
On Thursday, Exscientia plc EXAI agreed to merge with Recursion Pharmaceuticals Inc. RXRX.
Biotech firm Recursion to buy smaller peer Exscientia for $688 million
Recursion Pharmaceuticals , a biotech firm which uses artificial intelligence to discover new drug candidates, has agreed to buy smaller rival Exscientia for $688 million in an all-stock deal, accordi...
Exscientia Acquires Full Rights to Potential Best-in-Class CDK7 Inhibitor Ahead of Phase 1 Dose Escalation Data Readout
OXFORD, England--(BUSINESS WIRE)--Exscientia plc (Nasdaq: EXAI) today announced it has reached an agreement to acquire GT Apeiron's share of its oral CDK7 inhibitor programme, gaining full control of ...
Orthobond Expands its Board of Directors with Appointment of Eric Major as Chairman
PRINCETON, N.J.--(BUSINESS WIRE)--Orthobond Corporation, a leader in covalently-bound antibacterial surface technologies with broad applications in the medical device industry, today publicly announce...
Exscientia Launches AWS AI-powered Platform to Advance Drug Discovery
OXFORD, England--(BUSINESS WIRE)--Exscientia plc (Nasdaq: EXAI) today announced it will be expanding its work with Amazon Web Services (AWS) to use the cloud provider's artificial intelligence (AI) an...
Exscientia Plc Investors With Losses Are Encouraged By The Schall Law Firm To Start Communication Be Aware Of The Deadline In This Case
LOS ANGELES, CA / ACCESSWIRE / June 25, 2024 / The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Exscientia plc ("Exscientia" or ...
EXAI Today Is The Last Day that Investors can Lead Exscientia plc Fraud Lawsuit
LOS ANGELES , June 25, 2024 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Exscientia plc ("Exscientia" or "t...
The Schall Law Firm Urges Exscientia Plc Investors Who Have Suffered Losses To Initiate Communication Be Conscious Of The Time Limit In This Situation
LOS ANGELES, CA / ACCESSWIRE / June 24, 2024 / The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Exscientia plc ("Exscientia" or ...
Exscientia Plc Investors Who Have Incurred Losses Are Encouraged By The Schall Law Firm To Reach Out Please Be Mindful Of The Deadline In This Case
LOS ANGELES, CA / ACCESSWIRE / June 23, 2024 / The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Exscientia plc ("Exscientia" or ...
The Schall Law Firm Urges Investors Who Have Suffered Losses In Exscientia Plc To Make Contact Please Note The Deadline In This Case
LOS ANGELES, CA / ACCESSWIRE / June 22, 2024 / The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Exscientia plc ("Exscientia" or ...
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Exscientia
NEW YORK, June 21, 2024 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Exscientia plc (“Exscientia” or the “Company”) (NASD...
Investors With Losses In Exscientia Plc Are Encouraged By The Schall Law Firm To Reach Out Please Be Aware Of The Deadline In This Case
LOS ANGELES, CA / ACCESSWIRE / June 21, 2024 / The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Exscientia plc ("Exscientia" or ...
Investors Who Have Incurred Losses In Exscientia Plc Are Encouraged By The Schall Law Firm To Establish Contact Please Be Mindful Of The Deadline In This Case
LOS ANGELES, CA / ACCESSWIRE / June 20, 2024 / The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Exscientia plc ("Exscientia" or ...
Investors With Losses In Exscientia Plc Are Urged By The Schall Law Firm To Make Contact Be Mindful Of The Matter Time Limit
The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Exscientia plc ("Exscientia" or "the Company") (NASDAQ: EXAI) for violations o...
The Schall Law Firm Is Urging Investors Who Have Suffered Losses In Exscientia Plc To Reach Out. Please Be Aware Of The Time Limit In This Matter
LOS ANGELES, CA / ACCESSWIRE / June 18, 2024 / The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Exscientia plc ("Exscientia" or ...